Health Condition 1: null- Patients with panic disorder and hypertension.
Conditions
Interventions
None listed
Sponsors
King Georges Medical University Department of Geriatric Mental health
Eligibility
Inclusion criteria
Inclusion criteria: -Diagnosed panic disorder/panic attacks/generalised anxiety disorder who are otherwise suitable for SSRI therapy -Diagnosed hypertension and on at least one medication for hypertension -Compliant patient with access and availability to attend at least three (3) additional hospital sessions
Exclusion criteria
Exclusion criteria: -Cardiovascular Instability, such as history of myocardial infarction, arrhythmias or stroke -Hypotension -Currently active malignancy -Pregnancy or Breast-feeding -Involvement in another clinical trial -Current or recent (within 90 days) DSM-IV Major Depressive Disorder. -Hypersensitivity to, or currently using, any serotonergic medicines, such as tryptophan, tramadol etc -Contra-indication to serotonergic medicines
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Whether Sertraline is successful as adjunctive therapy to standard antihypertensive medications in lowering blood pressure in those with anxiety/panic disorders. Timepoint: 12 months | — |
Primary
| Measure | Time frame |
|---|---|
| Change in the scores for panic/anxiety disorder over 4 week period. Timepoint: 12 months | — |
Countries
Australia, India
Contacts
Public ContactDr Shrikant Srivastava
King Georges Medical University
Outcome results
None listed